Clinical Trial Update: Flibanserin Randomized Withdrawal Trial in Pre-menopausal Women [Phase 3]

View source ↗

Summary

Phase 3 randomized withdrawal trial of flibanserin in premenopausal women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoactive Sexual Desire Disorder

Drugs mentioned

• Flibanserin (Flibanserin)

Snippet

Sponsor: Sprout Pharmaceuticals, Inc | Conditions: Sexual Dysfunctions, Psychological | Phase 3 | Status: COMPLETED